ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Included in China’s National Essential Drugs List, Can Epclusa Get a Second Wind in China? (2)
November 21, 2018I mentioned in previous articles that genotypes of Chinese hepatitis C patients are mainly 1b and 2a/c, with the number of hepatitis C patients of about 26 million in total but treatment rate of less than 0.5%! The market space is huge. -
Included in China’s National Essential Drugs List, Can Epclusa Get a Second Wind in China? (1)
November 20, 2018The 2018 Edition National Essential Drugs List of China was officially published on October 25, 2018, which attracts extensive attention of the industry.
Pharma Sources Insight January 2025
